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INTRODUCTION 
The history of spinal anesthesia dates back since August 15, 1898 
when Gustav August Bier performed the first spinal anesthesia with cocaine. 
Then came Arthur E. Barker who determined several factors involved in the 
spread of local anesthetic in subarachnoid space. It was Rudolph Matas who 
first used a spinal additive morphine with cocaine to enhance neuraxial 
anesthesia. 
 Several factors have been determined since the introduction of spinal 
anesthesia, till date and in evolution that modify the effects, extent or 
duration of spinal anesthesia. 
 Bupivacaine is the commonly used local anesthetic in spinal 
anesthesia and several spinal additives, commonly the opioids are added to 
enhance the block and duration of spinal anesthesia. Each of the drug added 
as spinal additive has its own advantages and disadvantages. The ease of 
administering spinal anesthesia and its superior analgesic property has 
gained popularity over general anesthesia. 
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AIM OF THE STUDY: 
 To compare the effects of intrathecal fentanyl with 0.5 % Hyperbaric 
Bupivacaine and clonidine with   0.5% Hyperbaric Bupivacaine with control 
group of patients who received only 0.5% Hyperbaric Bupivacaine.  
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ANATOMY FOR SUBARACHNOID BLOCK 
       The vertebral column is made up of 33 vertebras 7 cervical, 12 
thoracic, 5 lumbar, 5 sacral (fused), 3 or 4 coccyx (fused). It has two 
primary curvatures determined in utero and 2 secondary curvatures of 
developmental origin. The importance is that in supine position the highest 
point is L3 and lowest point is T5. 
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Line  of  TUFFIER  -  It  is a  topographic landmark for spinal anesthesia 
where  a line  drawn  along  the  crests  of  iliac  bone  passes  through  spine   
of L4  in  sitting  position  and  L4-5 interspace in lateral position.  
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A lumbar vertebra contains a broad kidney shaped body, a thick and 
notched pedicle connecting body with the slender and long transverse 
process, short and broad laminae and a horizontal spine. The superior  
articular facets face backwards and inwards while the inferior articular 
facets face forwards and outwards 
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Ligaments – The supraspinous ligament is a strong, thick, fibrous  
band connecting the apices of spine from C7 to sacrum. In the cervical 
region it is specialized as ligamentum nuchae and extends from occipital 
protruberance to C7. 
 
 The interspinous ligament is a thin fibrous structure connecting 
adjascent spines which blends anteriorly with ligamentum nuchae and 
posteriorly with supraspinous ligament. 
 The ligamentum flavum is a yellow elastic tissue extending between 
antero-inferior surface of upper laminae to antero-superior surface of lower 
laminae. 
 
 
 
 12
The spinal cord has three covering meninges – the outer dura mater, 
the pia mater internally and the arachnoid mater inbetween. The dura  mater 
is  an extension of  cranial  dura  which  is  attached  above  to  the  foramen  
magnum  and  posterior  aspect  of  C2,3  cervical vertebra, anteriorly  to  
the posterior  longitudinal  ligaments, posteriorly  it  is  free. Laterally it 
prolongs  along  with  the  nerve  roots  and  blends  with  the  epineurium  
of nerve  roots  and  inferiorly  it  ends  at  the  level  of  S2. 
 
 The  arachnoid  membrane is a an avascular delicate  membrane 
which is resistant  to  the  penetration  of  drugs. It is an extension  from  the  
cranial arachnoid  membrane  and  it  lines  along  with  the  dural  sheath. 
 
 The pia mater is a vascular membrane which closely invests the brain 
and spinal cord along its fissures, sulci and gyri. The pia is thickened 
anteriorly to form linea splendens along the length of anterior median 
fissure. The denticulate ligaments are folds of pia mater attached lataerally 
to the dural sheath and they act as struts to hold the spinal cord. Filum  
terminale  is  an  extension  of  pia  mater   from   end  of  conus medullaris  
to  coccyx. 
 The compartments formed by the spinal meninges are the 
subarachnoid space, the  subdural  space, and  the  epidural  space  out  of  
which  our  space  of  interest  is  subarachnoid  space. 
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 The subarachnoid space contains CSF, spinal nerve roots, blood 
vessels, and  by  incomplete  trabecula – the  posterior  subarachnoid  
septum, And  also  traversed  by  ligamentum  denticulatum. This space 
extends upto S2. 
 
Fate of local anesthetic in this space is 
- Dilution  and  mixing  in  CSF 
- Uptake  and  fixation  by  neural  tissues 
- Vascular  absorption  and  elimination 
 
Spinal cord is about 45 cm.  In length extending upto L1 in adults and 
L3 in infants. Upto the   3rd month of intrauterine life spinal cord extended 
through out the vertebral column. The spinal cord is enlarged at the cervical 
and lumbar level corresponding to the nerve supply of upper and lower 
limbs. The   tapering end of the spinal cord is the conus medullaris  .The   
blood   supply  of  spinal  cord  is  with   one  anterior  spinal artery  formed  
by    fusion  of  two  branches  from  either  side  of  vertebral artery  which   
runs  in  anterior  median  fissure  supplying  anterior  two  thirds of  spinal  
cord. Two posterior spinal arteries formed from corresponding sites  of  
posterior  inferior  cerebellar  artery  supplies  posterior  one  third  of spinal  
cord. Communicating branches from corresponding segmental arteries 
called radicular arteries  from  vertebral, ascending  cervical, posterior 
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intercostals, spinal  lumbar,  lateral  sacral  arteries. Arteria radicularis 
magna is  the  largest  of  the  contribution  which  is  a  branch  from  
descending Aorta. Venous  drainage  is  through  plexus  of  veins  in  the  
pia mater, there are 6 longitudinal plexiform channels. 
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Site of Action of spinal anesthesia: 
 
 The local anesthetic injected in subarachnoid space acts on the spinal 
nerve roots and blocks its conduction. Hence the posterior nerve root 
carrying somatic and visceral sensation and anterior nerve roots carrying 
motor and autonomic outflow are blocked. 
Contraindications for spinal anesthesia: 
  
Absolute 
 
• Patient refusal  
 
• Infection at the site of injection 
 
• Coagulopathy 
 
• Severe hypovolemia 
 
• Severe  aortic stenosis 
 
• Severe  mitral  stenosis 
 
• Herniation of cerebellar  tonsils (↑ICT) 
 
Relative 
 
• Sepsis  
 
• Uncooperative patient 
 
• Pre-existing neurological deficits 
 
• Demyelinating lesions 
 
• Severe spinal deformity 
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Complications of spinal anesthesia: 
 
Immediate 
 
• Hypotension 
 
• Bradycardia 
 
• Cardiac  arrest 
 
•  Dyspnoea 
 
• Nausea 
 
• Vomiting 
 
• Shivering 
 
• Anxiety and  apprehension 
 
• High  spinal 
 
• Traumatic spinal cord or nerve  root  puncture 
 
• Broken needle 
 
Delayed 
 
• Post-operative urinary retention 
 
• Post-dural puncture headache 
 
• Backache 
 
• Transient neurological symptoms 
 
• Epidural hematoma 
 
• Meningitis / arachnoiditis 
 
• Epidural abscess 
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Factors affecting Block Height: 
 
Patient factor 
 
• Age 
 
• Height 
 
• Weight 
 
• Gender 
 
• Intra abdominal  pressure 
 
• Anatomy  of  spinal  column 
 
Technique of injection 
 
• Site of  injection 
 
• Direction  of  needle  and  bevel 
 
• Use  of  barbotage 
 
• Rate  of  injection 
 
Charecteristics of spinal fluid 
 
• Volume 
 
• Pressure 
 
• Density 
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Charecteristics of anesthetic solution 
 
• Density 
 
• Amount 
 
• Concentration 
 
• Temperature 
 
• Volume 
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PHARMACOLOGY OF THE DRUGS USED 
 
Bupivacaine: 
  
It was first introduced by Evenstam  
First came in to clinical use in 1963. 
 It is an amide Local Anaesthetic (1-butyl-N-(2, 6, dimethyll phenyl-
piperidine – 2 – Carboxamide). 
Structure: 
 
 
 
 
 
Formulations: 
As a clear 0.25%, 0.5%, 0.75% solution of bupivacaine 
hydrochloride. The hyperbaric solution used for subarachnoid block 
contains 80mg/ml of glucose. 
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Physiochemical Properties 
 Pka   : 8.1 
 Protein binding : 96% 
 Lipid solubility : 28 
 Elmination T½   : 210 mins 
 Clearance   : 0.47 l / min 
Mechanism of action: 
Local anaesthetics such as bupivacaine block the generation and the 
conduction of nerve impulses, presumably by increasing the threshold for 
electrical exitation in the nerve, by slowing the propagation of the nerve 
impulse, and by reducing the rate of rise of the action potential. In general, 
the progression of anaesthesia is related to the diameter, myelination and 
conduction velocity of affected nerve fibres. Clinically, the order of loss of 
nerve function is as follows.  
¾ Autonomic  
¾ Temperature cold  before  warmth 
¾ Pain 
¾ Touch 
¾ Pressure 
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¾ Motor 
¾ Vibration 
¾ Proprioception 
Routes of administration / dosage 
 Bupivacaine may be administered for infiltration, nerve blocks 
intrathecally, epidurally. The therapeutic dose of Bupivacaine is  
2-3mg/kg (with or without adrenaline) 
 The drug acts within 10-20 mins and has a duration of action of 5-6 
hours. 
Pharmacokinetics 
The absorption of Local Anaesthetic is related to 
• The site of injection (intercostal > epidural > brachial plexus > 
Subcutaneous) 
• The dose – a linear relationship exists between the total dose and the 
peak blood concentration achieved. 
• The presence of vasoconstrictors which delay absorption 
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The possible pathway for metabolism of bupivacaine include 
aromatic hydroxylation, N-dealkylation, amide hydrolysis and conjugation. 
Only the N-dealkylated metabolite N-desbutyl bupivacaine has been 
measured in the blood or urine. 
           Alpha-1 acid glycoprotein is the most important protein binding site 
of bupivacaine. 5% of the dose is excreted in the urine as pipcolloxylidine. 
16% is excreted unchanged clearance is 0.47 L/min and elimination T½ is 
about 210 min 
Systemic Toxicity 
Cardiovascular system: 
Bupivacaine is markedly cardiotoxic. It binds specifically to the 
myocardial proteins. In toxic concentrations the drug decreases the 
peripheral vascular resistance and myocardial contractility producing 
hypotension and possible cardiovascular collapse. Cardiotoxic plasma 
concentrations of bupivacaine is 8-10 mcg/mL. 
Central nervous system: 
 The principal effect of bupivacaine is reversible neural blockade. This  
leads to a characteristically biphasic effect in the CNS. During accidental 
over dosage or direct vascular injections the clinical signs are numbness of 
tongue, lightheadedness, visual and auditory disturbances, muscular 
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twitchings, tremors. The signs may progress to generalised convulsions of 
the tonic clonic nature. When plasma levels continue to rise, CNS excitation 
is rapidly superceded by depression drowsiness, disorientation & coma. The 
typical plasma concentration of Bupivacaine associated with seizures is 4.5 
– 5.5 mcg/mL. 
Clonidine: 
 Clonidine is the prototype drug of alpha-2 adrenergic agonist. 
 The selectiveity ratio α2: α1 is 220:1. 
 Synthesized in early 1960 as a nasal decongestant. 
The molecular formula is (2-(2, 6 – dicholorophenyl amino) – 2- 
imidazoline) 
Structure: 
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Preparations: 
 Tablets – 0.1 mg, 0.2 mg, 0.3mg 
 Preservative free parenteral forms 75µg/ml  
Trans dermal patch 
Routes of administration: 
 As  an  oral  premedication, intravenously, intrathecal  and  epidural  
additive, and  additive  for  regional  nerve  blocks. 
Pharmacokinetics: 
 Well absorbed orally with a bioavailability of 100% 
 Peak plasma concentration 60 - 90 min, 
 Elimination half time 9 - 12hrs.  
 50%  metabolized  in  the  liver  rest  excreted  unchanged  in  the  
urine. Transdermally the therapeutic plasma concentration will take 48 hrs. 
The  elimination  half  life  is  increased  in  patients  with  renal  
dysfunction. 
Pharmaco dynamics: 
 Clonidine acts on various systems in the body. 
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Cardio Vascular System 
 Clonidine has got both central action and peripheral action. 
Central Action 
 Activation of central α - 2 adrenergic receptors in medullary 
vasomotor centre inhibits the release of nor – epinephrine from the 
adrenergic neurons and reduces sympathetic outflow from the central 
nervous system. Further there is reduced discharge from the post ganglionic 
fibers of cardiac nerves and an increase in parasympathetic tone. 
 This results in decrease in blood pressure, heart rate, cardiac output, 
peripheral vascular resistance. Nucleus tractus solitarius, the site that 
modulates the autonomic control including vagal activity is an important 
central site for the action of clonidine. Other proposed sites of action are 
locus ceruleus, dorsal motor nucleus of vagus and nucleus reticularis 
lateralis. 
 Reduction in sympathetic tone is accompanied by lowering of plasma 
renin activity, decrease in renal vascular resistance and maintenance of 
renalblood flow even when the blood pressure is lowered. Vasopressor 
centers of the brainstem retain their sensitivity to baroreceptor control and 
hence postural hypotension is considerably less than the effects of drugs that 
act on the autonomic ganglia and peripheral adrenergic receptors. 
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The absence of fall in blood pressure when clonidine is given to 
tetraplegic with complete spinal cord transection above the level of 
sympathetic outflow also suggests a central site of hypotensive action. 
Peripheral Action  
These are mediated by inhibition of nor – epinephrine release from 
the peripheral pre-junctional nerve endings and by decreasing plasma 
concentration of nor-epinephrine. 
Coronary Circulation 
 The direct effect of α-2 agonist on coronary vasculature is 
vasoconstriction. However, this is offset by the generalised reduction in 
sympathetic outflow. 
Central Nervous System 
 Clonidine has got a sedative and anxiolytic action. The sedative effect 
of clonidine may be due to decreased tonic activity of the locus ceruleus 
which modulates the stimuli arriving in the central nervous system. It has 
got a potent spinal and supraspinal analgesic action. Clonidine has got 
opioid sparing effect and it reduces the anaesthetic requirements, reduces 
the MAC of halothane and isoflurane. 
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Respiratory System 
Clonidine has minimal bronchodilating and respiratory depressant activity. 
Endocrine System 
 Clonidine suppresses insulin secretion, decreases utilisation of 
glucose by tissues and may cause hyperglycemia. It inhibits the secretion of 
renin. 
Gastrointestinal System 
 Clonidine decreases salivary flow. It prevents intestinal ion & water 
secretion in the large bowel. 
Uses:   
1. Pre-anesthetic medication 
 Clonidine in dose 3-5 mcg/kg orally 60-120 mins prior to induction 
given as a premedicant provides sedation, anxiolysis, antisialagogue effect, 
attenuates the hemodyanamic responses to largyngoscopy and intubation, 
decreases the intra operative lability of blood pressure, heart rate and 
decreases post anesthetic shivering. 
 
 
 
 
 
 28
2. Spinal & Epidural Analgesia 
 Preservative free clonidine injected epidurally (2-10mcg/kg) or in to 
subarachnoid space (0.3 – 1mcg/ kg) produces dose dependant analgesia. It 
acts on the substantia gelatinosa of the spinal cord, inhibits substance `p' 
release and nociceptive neuron firing produced by noxious stimuli. 
3. Prolonging the effects of Reginal Anaesthesiao 
 When added to local anaesthetic solution prolongs the brachial plexus 
block and caudal analgesia. 
4. Treatment of Post-anesthetic shivering. 
 Injection clonidine 75µg given intravenously inhibits or stops 
shivering mechanism by inhibition of central thermoregulatory control. 
5. Diagnosis of Pheochromocytoma 
 Lack of suppression of plasma nor-epinephrine to less than 500 
picogram / ml, 3 hours after a oral dose of 0.3 mg clonidine suggests 
Pheochromocytoma. 
6. Treatment of Hypertension 
 It is not used as a first line antihypertensive 
7. Induced hypotension 
 Clonidine is a useful adjunct in inducing deliberate hypotension. 
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Adverse Effects 
 Clonidine can cause bradycardia, hypotension, sedation and dry 
mouth occur in 50% of cases. It may cause dryness of nose and eyes. It may 
sometimes cause parotid swelling and pain. Less common side effects like 
sleep disturbances with vivid dreams or nightmares restlessness, depression 
and impotence may occur in some patients. 
Clonidine withdrawal phenomena 
 Abrupt discontinuation of clonidine results in headache, 
apprehension, tremors abdominal pain, sweating, tachycardia hypertension. 
It occurs usually 18-24 hours after stopping the drug. It occurs because of 
increased sympathetic discharge resulting in increased plasma and urine 
catecholamine concentration. It is dose related, occurring rarely in patients 
taking a daily dose of clonidine 0.3mg or less and more frequently upon 
discontinuation of higher doses of > 1.2mg/day. 
Drug Interactions 
 
1) Diuretics potentiate hypotension caused by clonidine  
2) Tricyclic antidepressants inhibit the antihypertensive effect of 
clonidine by a unknown mechanism. 
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Overdose 
 It results in depression of sensorium, transient hypertension followed 
by hypotension and bradycardia. It may cause respiratory depression and 
miosis resembling opioid overdose. Treatment is ventilatory support and 
circulatory support with crystalloids, colloids ionotropic support. 
Fentanyl : 
 It is a synthetic opioid. 
 It is a phenylpiperidine derivative structurally related to pethidine. 
 It  is  a  µ  receptor  agonist  75 – 125  times  more  potent  than  
morphine, but  has  a  shorter  duration  of  action. 
Structure: 
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Preparations: 
 Parenteral forms - preservative free 50µg/ml 
 Oral transmucosal fentanyl 
 Transdermal patch  
Routes of administration: 
 Oral, intravenous, intramuscular, intrathecal, epidural, transdermal 
Pharmacokinetics: 
 Property     Value 
  Pka            8.4 
 % of unionised at PH 7.4   <10 
 % bound to plasma protein  84 
 t½ μ      1-2 mins 
  Volume of distribution      0.5 – 1.0L/kg 
  Clearance          10‐20mL/kg/min 
 Hepatic extraction ratio   0.8 – 1.0 
 Effect site equilibration time            6.4 min. 
It is metabolized in liver, by N-demethylation to norfentanyl, 
hydroxyl propionyl fentanyl, and hydroxyl propionyl norfentanyl. The 
demethylated products have less pharmacologic activity, and is excreted 
unchanged in urine. Its  short  duration  of  action  is  due  to  its  rapid  
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redistribution  to  fat and  skeletal  muscles .The  lungs  also  serves  as  an  
inactive  storage  site with 75 %  undergoing  first  pass  pulmonary  uptake. 
Pharmacodynamic effects: 
Neurophysiologic effects: 
Analgesia – Mainly nociceptive pain but not neuropathic. Its 
analgesic  action  is  both  spinally  as  well  as  supraspinally  mediated no 
matter  in  which  route  it  is  administered. Supraspinally it hyperpolarizes 
the second order neurons there by inhibiting ascending transmission of pain 
impulses. Spinally the mechanism is it decreases excitatory 
neurotransmitters  like  substance-p  from  the  primary  sensory  neurons 
The opioid receptors  are  concentrated  in  the  laminae-2  of  the  substantia 
gelatinosa. It decreases the MAC of inhalational agents. There will be no 
loss of consciousness except in high doses. Fentanyl produces chest wall 
rigidity. It also produces pruritis in face. 
Cardiovascular system: 
 It  decreases  the  heart  rate  and  minimal  decrease  in  cardiac  
output and  blood  pressure  but  relatively  more  hemodynamically  stable  
than  morphine  as  it  does  not  release  histamine.No  effect  on  
myocardial contraction . It decreases  baroreceptor  reflex  in  infants. 
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Respiratory system: 
 It is a respiratory depressant by acting on the medullary respiratory 
centre.depresses tracheal mucociliary outflow, and also depresses somatic 
and autonomic responses to intubation. It decreases hypoxic ventilatoty 
drive as well as carbon-dioxide stimulant effect. Its respiratory depressant 
effects can be effectively reversed by naloxone. 
Endocrine system: 
 It decreases stress response by modulating nociception in the 
neuraxis. It also inhibits pituitary adrenal axis. 
GIT: 
Nausea  and  vomiting  and  it  also  delays  gastric  emptying  time. It 
also produces biliary colic in conscious patients. 
Renal: 
 It produces urinary retention by augmenting detrusor muscle tone and 
increasing vesical sphincter tone. 
Placenta: 
 No placental barrier for opioids. The feto-maternal ratio is 0.57. 
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conclude that the quality of spinal anesthesia with good 
hemodynamic stability prevailed when fentanyl or sufentanyl was  
added. 
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STUDY DESIGN 
Prospective randomised control study 
Ethical committee approval was obtained. 
Pre – operative assessment done for all cases 
      Informed consent obtained from all patients 
Inclusion criteria: 
 ASA PS – 1 & 2 patients 
Both male and female patients 
Age within 20 and 40 years 
Patients who have given consent 
Elective surgeries 
Exclusion criteria:  
 Contraindication for spinal anesthesia 
ASA PS 3, 4 & 5 patients 
Patients who have not given consent 
Age more than 40 years and less than 20 years  
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Drugs used: 
¾ 0.5 % Hyperbaric Bupivaccaine  
¾ Preservative free Fentanyl  
¾ Preservative free Clonidine  
¾ 0.9 % Normal Saline  
Groups: 
A – 15 mg of 0.5% bupivacaine (H) + 0.5ml of Normal Saline 
B – 15 mg of 0.5% bupivacaine (H) + 25 µg of Fentanyl  
C – 15 mg of 0.5% bupivacaine (H) + 50 µg of clonidine  
       Corrected to a volume of 0.5ml by adding Normal  Saline 
Study methodology:  
45 Patients were assigned to 3 groups 15 each Randomisedly and 
after obtaining informed consents from all patients study was done.   
Preoperative vitals were recorded and all patients were standardly started  
with  18G  Venflon  and  preloaded  with  500ml  of  Ringer  Lactate  fluid  
15  minutes  before  the  time  of  spinal  anesthesia. No patients were 
sedated intra operatively. Table was ensured to be horizontal before spinal 
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anesthesia. Under  aseptic  precautions  spinal  anesthesia  was  given  to  all  
patients in right lateral position, with 25G Quincke-Babcocks spinal  needle, 
and  in  L3-4  space. Hypotension  was  defined  as  less  than  20%  from 
the basal mean arterial pressure and treated with  ephedrine & intravenous 
fluids and bradycardia less than 60 and treated with  atropine. 
Monitors: 
 Noninvasive blood  pressure  for  every  five minutes in the first  hour 
and every ten minutes thereafter, Continuous five lead Electrocardiogram, 
And pulse-oximeter. 
Clinical parameters that were observed: 
  Maximum sensory level blocked (Until grade 3) 
       Time to achieve maximum sensory level 
        Sensory Regression time to L1 (Until grade 0) 
  Onset of grade 4 motor block 
    Regression time to grade 1 motor block 
  Sedation score 
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Assessment of sensory blockade: 
 Hollman’s  Scale 
 Grade 1    Normal sensation of pin prick  
Grade 2       Pin prick felt as sharp pointed but weaker compared                               
with the same  area in other side. 
Grade 3 Pin prick felt as touch with blunt object 
Grade 4 No perception of pin prick 
Assessment  of  sensory loss  to  pain  was  done  by  using  24 gauge  
intramuscular  needle until  the  patient  had  grade 3   Sensory  block.   
Assessment of Motor Blockade: 
 Bromage score: 
 
 
Grade  Criteria  Degree of Block  
I  Free movement of legs and feet  (0%)  
II  Just able to flex knees with free movement of feet   (33%)  
III  Unable to flex knees, but with free movement of feet   (66%)  
IV  Unable to move legs or feet   (100%)  
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Assessment of Sedation Level : 
Ramsey Sedation Score: 
 1 - Anxious or agitated or restless 
2 – Cooperative, oriented  
3 – Responds only to commands but awake 
4 – Asleep and brisk response to commands 
5 – Asleep and sluggish response to commands 
6 – No response to auditory stimulus 
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STATISTICAL ANALYSIS 
Demographic details: 
Age distribution 
S.No. Age Group in 
years 
Group A  Group B  Group C  
1. 20-25 4 3 3 
2. 25-30 3 5 2 
3. 30-35 2 4 4 
4. 35-40 6 3 6 
 
ANOVA 
 Sig. 
Between Groups .681 
Within Groups  
  
 
Here the significance value is >0.05. Implies  there  is  no much 
statistical  differences  in  the  age  distribution  in  all  three  groups. 
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Height 
 
 
 
 
95% Confidence Interval 
for Mean 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
Lower 
Bound 
Upper 
Bound 
1 15 165.60 6.243 1.612 162.14 169.06 
 
2 
 
15 
 
165.20 
 
6.213 
 
1.604 
 
161.76 
 
168.64 
 
3 
 
15 
 
164.67 
 
5.367 
 
1.386 
 
161.69 
 
167.64 
    
 
ANOVA 
 Sig. 
Between Groups .912 
Within Groups  
  
The  average  height  distribution  in  all  three  groups  were  around  
165cm  with  not  of  much  variation  in  the  standard  deviation. Here  also  
the significance value is >0.05. Implies  there  is  no  much  statistical  
differences  in  the  height  distribution  in  all  three  groups. 
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Weight 
 
 
 95% Confidence Interval 
for Mean 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
Lower 
Bound 
Upper 
Bound 
1 
 15 70.53 7.549 1.949 66.35 74.71 
2 15 69.07 5.934 1.532 65.78 72.35 
 
3 
 
15 
 
70.33 
 
8.191 
 
2.115 
 
65.80 
 
74.87 
    
    
 
ANOVA 
 Sig. 
Between Groups .837 
Within Groups  
  
 
 Since  the  study  is  a  randomized  study  the  demographic  
‘p’ values  were  all  insignificant. All  these  parameters  age  
,height  and  weight  were  all  evenly  distributed  in  all  three  
groups. 
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Clinical parameters: 
Maximum Sensory Level Blocked 
 
 
95% Confidence Interval 
for Mean 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
Lower 
Bound 
Upper 
Bound 
1 15 5 1.424 .368 4.41 5.99 
 
2 
 
15 
 
4 
 
.884
 
.228
 
4.44
 
5.42 
 
3 
 
15 
 
5.00 
 
1.254 
 
.324 
 
4.31 
 
5.69 
    
 
 
 
 
 Sig. 
Between Groups .821 
Within Groups  
Total  
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Time to achieve maximum sensory level blocked: 
 
 
 
 
95% Confidence Interval 
for Mean 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
Lower 
Bound 
Upper 
Bound 
1 15 28.33 7.943 2.051 23.93 32.73 
 
2 
 
15 
 
22.80 
 
7.785 
 
2.010 
 
18.49 
 
27.11 
 
3 
 
15 
 
24.20 
 
7.213 
 
1.862 
 
20.21 
 
28.19 
    
 
X – 
Groups. 
Y- Time. 
 
p – value  by ANOVA  was  .133  which  shows  that  statistically  it  
is  insignificant  but  seeing  the  mean  values  the  time  to  achieve  this  is  
short  with  group B. 
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Sensory  Regression  to  L1  : 
 
 
 
 
95% Confidence Interval 
for Mean 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
Lower 
Bound 
Upper 
Bound 
1 15 171.20 19.969 5.156 160.14 182.26 
 
2 
 
15 
 
231.00 
 
47.442
 
12.249
 
204.73
 
257.27 
 
3 
 
15 
 
250.67 
 
35.950 
 
9.282 
 
230.76 
 
270.57 
    
 
     . 
 
p- value by ANOVA was  0  hence  post  hoc  test  was done to 
determine  the  intergroup  significance  level 
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POST HOC TEST  
 
 
(I) 
GRO
UP 
(J) 
GRO
UP 
 
95% Confidence 
Interval 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
Lower 
Bound 
Upper 
Bound 
1 2 -59.800* 13.236 .000 -86.51 -33.09 
3 -79.467* 13.236 .000 -106.18 -52.76 
2 1 59.800* 13.236 .000 33.09 86.51 
3 -19.667 13.236 .145 -46.38 7.04 
3 1 79.467* 13.236 .000 52.76 106.18 
2 19.667 13.236 .145 -7.04 46.38 
 The mean difference is significant at the 0.05 level. 
 
Here  the  p-value  between  Group B  & C  is  0.145  which  is 
insignificant  but  between  Group A  and  other  groups  it  is  0   
 
and  so  statistically  significant. So  sensory    regression  to  L1  is   
 
increased  in  B  &  C. 
 
 
 
ONSET OF GRADE 4 MOTOR BLOCK IN MINUTES 
 
 
95% Confidence 
Interval for Mean 
 
N Mean 
Std. 
Deviation
Std. 
Error 
Lower 
Bound 
Upper 
Bound 
1 15 10.00 2.619 .676 8.55 11.45 
 
2 
 
15 
 
6.87 
 
4.138 
 
1.068 
 
4.58 
 
9.16 
 
3 
 
15 
 
5.73 
 
1.870 
 
.483 
 
4.70 
 
6.77 
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The  p – value  by  ANOVA  was  0.001  and  hence  post  hoc  test  
was  done  to  determine  the  intergroup  significance  level. 
POST HOC TEST 
 
(I) 
GRO
UP 
(J) 
GRO
UP 
 
95% Confidence 
Interval 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
Lower 
Bound 
Upper 
Bound 
1 2 3.133* 1.105 .007 .90 5.36
3 4.267* 1.105 .000 2.04 6.50
2 1 -3.133* 1.105 .007 -5.36 -.90
3 1.133 1.105 .311 -1.10 3.36
3 1 -4.267* 1.105 .000 -6.50 -2.04
2 -1.133 1.105 .311 -3.36 1.10
*. The mean difference is significant at the 0.05 level. 
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This  test  implies  that  the  p-value  between  group B & C  is  0.311  
which  is  insignificant  while  group  A  compared  to  group B & C is  
significant. 
 
Regression  To Grade 1 Motor Block In Minutes 
 
 
 
95% Confidence Interval 
for Mean 
 
N Mean 
Std. 
Deviation
Std. 
Error
Lower 
Bound
Upper 
Bound 
1 15 188.67 20.999 5.422 177.04 200.30 
 
2 
 
15 
 
234.20 
 
31.412 
 
8.111 
 
216.80 
 
251.60 
 
3 
 
15 
 
273.00 
 
26.979 
 
6.966 
 
258.06 
 
287.94 
       
 
 
 
 
X –Group 
Y- Time (minutes) 
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The  p- value  by  ANOVA  is  0  and  hence  significant  , so  post 
hoc  test  Was   done  to  determine  intergroup  significance  . 
POST HOC TEST 
 
(I) 
GRO
UP 
(J) 
GRO
UP 
 
95% Confidence 
Interval 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
Lower 
Bound 
Upper 
Bound 
1 2 -45.533* 9.788 .000 -65.29 -25.78 
3 -84.333* 9.788 .000 -104.09 -64.58 
2 1 45.533* 9.788 .000 25.78 65.29 
3 -38.800* 9.788 .000 -58.55 -19.05 
3 1 84.333* 9.788 .000 64.58 104.09 
2 38.800* 9.788 .000 19.05 58.55 
*. The mean difference is significant at the 0.05 level. 
 
 
Here  all  the  p  values  were  significant  and  hence  each  and  
every  group  is  also statistically  proved  to  be  significant   and   distinct. 
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Hemodynamic Variables: 
 
  
BP  at  15  min  
 
  
N  Mean  Std. Deviation  Std. Error 
 SYSTOLIC  1 15 102.93 10.872 2.807 
 
2 
 
15 
 
98.00 
 
6.928 
 
1.789 
 
3 
 
15 
 
91.47 
 
8.052 
 
2.079 
     
 DIASTOLIC  1 15 58.00 7.635 1.971 
 
2 
 
15 
 
55.60 
 
10.802 
 
2.789 
 
3 
 
15 
 
47.20 
 
6.625 
 
1.710 
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BP   AT  60 MIN   
  
N  Mean  Std. Deviation  Std. Error 
 SYSTOLIC  1  15 108.56 10.795 2.787 
2  15 100.20 6.201 1.601 
3  15 96.33 5.150 1.330 
     
 DIASTOLIC  1  15 68.20 7.183 1.855 
2  15 65.00 7.241 1.870 
3  15 52.40 4.212 1.088 
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HEART RATE   
N  Mean  
Std. 
Deviation  
Std. 
Error  
At 15 min. 1  15 77.07 9.823 2.536 
2  15 73.13 8.123 2.097 
3  15 64.47 7.210 1.862 
     
At  30 min.  1  15 89.07 9.354 2.415 
2  15 73.87 11.438 2.953 
3  15 70.80 8.833 2.281 
     
 
 
HEART RATE   
N  Mean  
Std. 
Deviation  
Std. 
Error  
At 60 min. 1  
15 85.01 12.823 2.536 
2  
15 84.13 9.123 2.097 
3  
15 71.36 5.210 1.862 
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RAMSEY  SEDATION SCORE  
     Score   
                              GROUP  
              1  2  3  
                    
1  
                     
               15   
  
3  
0  
                        
 
                   
2  
  11  0  
    
 
                   
3  
  1  7  
    
 
                   
4  
  0  8  
    
 Total  Count                      
15  
 
15  
 
15  
    
 
Here  the  p  value is  0  and  hence  the  test  is  significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 57
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RESULTS 
 
¾ Onset of  grade 4  motor  block  was  shorter  in  group 2  and  3 
 
with an  average  of  around  5 to 7 minutes. 
 
¾ Regression  to grade 1 motor block  is significantly  prolonged 
 
In group 3 and 2 but group 3 is longer than 2. 
 
¾ Sensory regression to  L1  is prolonged  in the  additive  groups   
 
     but not  significantly  prolonged while comparing these two  
 
groups. 
 
¾ Maximum  height of  dermatomal  block  was  not  significant 
 
in  all these  groups  and  the  time  to  achieve  it  was  also   
 
not significant. 
 
¾ Hemodynamic  variables   were  relatively  lower  in   
 
clonidine group. 
 
¾ All the patients in clonidine group were well sedated.  
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DISCUSSION 
 
 The study results show significant prolongation of sensory and motor 
blockade with clonidine. The average duration of motor blockade was 273 
minutes which is ahead by 40 minutes compared to the average value with 
fentanyl and 85 minutes ahead with control group. The average  duration  of  
sensory blockade was 250.67 minutes in clonidine  group  while  in  
fentanyl   group   it  is  231  minutes   and  in control   group  171 minutes. 
Even  though  there  is  a  minimal  blood  pressure variability  with  
clonidine  which  have  been  managed  with  ephedrine  and intravenous 
fluids  there  was  no  significant  bradycardia. 
   
With clonidine it has an additional  advantage  of  sedating  thepatient 
compared  with  fentanyl  and  it  also  lacks  other  side  effects  and 
respiratory  depression  that  an  intrathecal  opioid  will  have. The sedative 
property  of  clonidine  can  be  observed  in  any  route  the  drug  is  given 
intrathecal, epidural, and  nerve  blocks.   
Clonidine a selective partial agonist for α-2 adrenoreceptors centrally 
and peripherally. The analgesic effect following its intrathecal 
administration is mediated spinally through activation of post-synaptic α-2 
adrenoreceptors in the substantia gelatinosa of spinal cord and it works by   
blocking the conduction of C and Aδ fibres. The sedative property of the 
drug is due to its agonist action in α-2A receptors in the locus ceruleus of 
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the brain stem. Even though both the drugs fentanyl and clonidine  produced  
an  intense  sub-arachnoid  block clonidine is statistically significant  in  
prolonging  the  blockade. Van der werff and C.J.Kalkmann in their study in 
using clonidine with hyperbaric bupivaccaine for caesarean section had a 
conclusion of prolonging sub-arachnoid blockade with no relevant maternal 
and neonatal side effects. In  another  study  by  Stephen  strebel et al  
compared  various  doses  of clonidine as spinal additive to hyperbaric 
bupivaccaine  37.5, 75, and  150 microgram and the results were  
prolongation  of  spinal  anesthesia  in  a dose  dependant  manner  but  the  
sedation  score  was  not  different. The hemodynamic variables had more 
variability in higher doses. 
 
Fentanyl a lipophilic opioid acts directly on the µ receptor In the  
laminae  2 of  the  substantia  gelatinosa of spinal cord where by it provides 
pre-synaptic  inhibition of the neurotransmitter  release  although minimal  
post-synaptic  inhibition also occurs by hyperpolarizing  the  second  order 
neurons. The side effects of intrathecal opioids  which  is  lacked  by the α-2 
agonists are pruritis in the face, neck and upper thorax, nausea  and 
vomiting, urinary retention, depression of ventilation which  is  not  usually 
observed in such  low  doses  of  fentanyl and  also  due  to  its  lipophilicity. 
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To summarize  clonidine  and  fentanyl  prolongs  the  duration  of 
spinal  anesthesia  but  clonidine  has  a  longer  duration  than  fentanyl  and  
there  is  beneficial  property  of  sedation  with  clonidine  and  it  also  
lacks  the  adverse  property  of  intrathecal  opioids. 
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CONCLUSION 
 
  
CLONIDINE when used as a spinal additive to hyperbaric 
bupivacaine in healthy adults it qualitatively prolongs the duration of both 
sensory and motor block of spinal anesthesia with insignificant 
hemodynamic variation which can be easily managed. Whereas fentanyl 
also prolongs the spinal Anesthesia but not to the extent of Clonidine, 
without any significant hemodynamic changes. Clonidine has an additional 
advantage of arousable sedation. 
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PROFORMA 
 
Group      :         1                         2                       3 
 
Name    : 
 
Age    :   (20 - 40 years only) 
 
Sex    :    
 
I.P.  No.   : 
 
Unit    : 
 
Diagnosis   : 
 
Surgical   
procedure       : 
 
Pre- operative Examination:  
                     
                        Routine H/O     
                          
                         Height  
 
      Weight 
 
      Pulse rate 
 
      B.P. 
 
      R.R. 
 
      C.V.S. 
 
      R.S 
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Investigations: 
                      Hb% 
     
 Blood sugar 
 
                      Serum Urea 
   
   Serum Creatinine 
 
   B.T. 
 
   C.T. 
 
  ASA – PS  Grade:   (1&2 only) 
   
  Procedure: 
   
  Date & Time of SAB: 
 
  Maximum sensory level blocked: 
 
  Time to achieve max.sensory block: 
 
  Motor block - Bromage score 
 
   
Grade Criteria Degree of Block 
I Free movement of legs and feet Nil (0%) 
II Just able to flex knees with free movement of feet Partial (33%) 
III Unable to flex knees, but with free movement of feet Almost Complete (66%) 
IV Unable to move legs or feet  Complete (100%) 
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Onset of Grade 4 block: 
           Sensory regression to L1 time: 
  Regression time to Grade 1 block: 
  Duration of surgery: 
                    Sedation score: 
  
Intra-0perative vitals: 
 
Time 
in  
Min. 
5 10 20 30 40 50 60 70 80 90 100 110 120 140
P.R               
B.P               
SpO2%               
 
Intravenous fluid replacement: 
 
Blood no. of units used: 
 
Post-operative vitals: 
 
   Time in 
hrs. 
      1       2       3        4        5      6 
P.R       
B.P       
Spo2%       
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CONTROL GROUP 
 
 
 
 
 
 
S.No. Heart 
rate  
5 min. 
Heart rate  
10 min. 
Heart rate 
15 min. 
Heart 
rate 
30 min. 
Heart rate 
60 min. 
HR at 90 
min 
Bp at 5 
min 
BP at 10 
min 
BP at 15 
min 
BP at 30 
min 
BP at 60 
min 
BP at 
90 min 
Ramsey 
Sedation 
Score 
Ephedrine 
(mg) 
Atropine 
(mg) 
1 89 80 78 88 90 92 100/60 110/68 130/70 110/50 132/70 130/70 1 0 0 
2 88 90 90 98 95 100 130/80 100/60 140/80 104/76 110/80 120/80 1 6 0 
3 85 87 88 90 100 96 110/70 112/64 
 
120/80 100/60 110/80 110/76 1 0 0 
4 70 75 67 80 85 82 90/50 110/68 120/70 90/60 120/70 120/72 1 12 0 
5 74 79 77 79 80 78 110/68 120/78 130/90 120/70 120/80 128/78 1 0 0 
6 60 68 60 110 99 95 90/60 100/60 100/70 80/40 102/70 110/70 1 24 0.6 
7 80 82 84 90 98 95 100/60 120/68 120/70 100/60 120/70 120/74 1 0 0 
8 74 76 72 80 85 84 92/68 120/72 120/70 102/60 110/70 110/70 1 6 0 
9 85 90 89 100 94 92 98/50 110/48 120/60 90/50 124/76 125/78 1 6 0 
10 78 84 80 90 96 91 140/90 140/80 140/80 110/60 132/80 132/80 1 0 0 
11 64 68 65 76 84 82 100/56 120/70 150/80 100/60 120/70 120/70 1 6 0 
12 80 77 78 88 90 86 140/90 130/70 140/80 112/58 110/60 110/60 1 0 0 
13 80 84 90 97 106 98 130/60 100/66 140/70 118/60 130/60 130/66 1 6 0 
14 71 76 70 90 88 88 100/70 90/66 110/80 100/50 110/60 110/70 1 6 0 
15 66 70 68 80 97 95 130/82 120/80 134/80 110/70 110/70 120/70 1 0 0 
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S.No. Heart 
rate  
5 min. 
Heart rate  
10 min. 
Heart rate 
15 min. 
Heart 
rate 
30 min. 
Heart rate 
60 min. 
HR at 90 
min 
Bp at 5 
min 
BP at 10 
min 
BP at 15 
min 
BP at 30 
min 
BP at 60 
min 
BP at 
90 min 
Ramsey 
Sedation 
Score 
Ephedrine 
(mg) 
Atropine 
(mg) 
1 89 80 78 88 90 92 100/60 110/68 130/70 110/50 132/70 130/70 1 0 0 
2 88 90 90 98 95 100 130/80 100/60 140/80 104/76 110/80 120/80 1 6 0 
3 85 87 88 90 100 96 110/70 112/64 
 
120/80 100/60 110/80 110/76 1 0 0 
4 70 75 67 80 85 82 90/50 110/68 120/70 90/60 120/70 120/72 1 12 0 
5 74 79 77 79 80 78 110/68 120/78 130/90 120/70 120/80 128/78 1 0 0 
6 60 68 60 110 99 95 90/60 100/60 100/70 80/40 102/70 110/70 1 24 0.6 
7 80 82 84 90 98 95 100/60 120/68 120/70 100/60 120/70 120/74 1 0 0 
8 74 76 72 80 85 84 92/68 120/72 120/70 102/60 110/70 110/70 1 6 0 
9 85 90 89 100 94 92 98/50 110/48 120/60 90/50 124/76 125/78 1 6 0 
10 78 84 80 90 96 91 140/90 140/80 140/80 110/60 132/80 132/80 1 0 0 
11 64 68 65 76 84 82 100/56 120/70 150/80 100/60 120/70 120/70 1 6 0 
12 80 77 78 88 90 86 140/90 130/70 140/80 112/58 110/60 110/60 1 0 0 
13 80 84 90 97 106 98 130/60 100/66 140/70 118/60 130/60 130/66 1 6 0 
14 71 76 70 90 88 88 100/70 90/66 110/80 100/50 110/60 110/70 1 6 0 
15 66 70 68 80 97 95 130/82 120/80 134/80 110/70 110/70 120/70 1 0 0 
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FENTANYL GROUP 
 
S.No Name/I.P.No. Age/Sex Procedure ASA 
status 
Height Weight Level of 
SAB 
Maximum 
Sensory 
Level 
Blocked 
Time to 
achieve 
maximum 
sensory level 
Onset of 
Grade      4 
motor 
block 
Sensory 
regression to 
L1 
Regression to 
Grade 1 motor 
block 
1 Elumalai 
921498 
22/M Right IMIL nailing 1 170 65 L3-4 T6 35 5 150 180 
2 Raghu 
924475 
37/M Left Femur DHS fix 1 168 70 L3-4 T5 20 4 200 225 
3 Ganesamoorthy 
924929 
38/M Right tibia Ilizarov ring 
application 
2 158 75 L3-4 T6 30 20 195 210 
4 Murugan 
924469 
35/M Left Ilizarov ring 
revision 
1 160 70 L3-4 T4 15 4 240 255 
5 Gunasekar 
922767 
30/M Left tibia IMIL nailing 2 171 59 L3-4 T5 20 5 300 270 
6 Duraibabu 
924304 
40/M Right tibia ORIF and 
plating 
1 169 67 L3-4 T5 35 7 230 240 
7 Solomon 
919749 
24/M Left tibia IMIL nailing 1 174 82 L3-4 T5 15 10 230 200 
8 Rhuthrakumar 
917926 
26/M Right Ilizarov ring 
revision 
1 159 70 L3-4 T6 6 3 280 260 
9 Dinesh 
913249 
32/M Left Ilizarov ring 
application 
2 157 65 L3-4 T5 25 6 310 300 
10 Shanthakumari 
940319 
30/F Right femur IMIL 
nailing 
1 164 70 L3-4 T5 20 5 300 260 
11 Pooja 
925789 
23/F Right tibia IMIL and 
Left patellaTBW 
2 166 74 L3-4 T6 25 10 180 200 
12 Elumalai 
931890 
33/M Left femurDHS fix. 1 170 74 L3-4 T4 20 7 210 230 
13 Ramesh 
915682 
29/M Left IMIL nailing 1 156 60 L3-4 T3 30 5 200 215 
14 Manimegalai 
918273 
32/F Right femoral condylar 
screw fix. 
1 167 65 L3-4 T4 22 6 230 240 
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15 Senthamarai 
937281 
30/F Right tibia IMIL nailing 2 175 70 L3-4 T5 24 6 210 228 
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S.No Heart rate at 
5 min  
Heart rate 
at 10 min 
Heart rate 
15 min. 
Heart rate 
30 min. 
Heart rate 
60 min. 
Heart rate 
90 min 
BP 5 min BP 10 
mkin 
BP at 15 
min 
BP at 30 
min 
BP at 60 
min 
BP at  90 
min. 
Ramsey 
Sedation 
Score 
Ephedrine 
(mg) 
Atropine 
(mg) 
1 60 76 70 84 80 82 110/66 100/60 110/70 100/50 116/70 120/72 2 0 0.6 
2 84 86 88 92 90 92 100/50 110/74 122/80 112/76 120/84 120/80 2 0 0 
3 
 
60 68 66 80 75 77 100/58 110/80 120/80 90/60 136/70 140/72 1 6 0.6 
4 63 72 70 75 74 76 94/68 100/68 118/70 90/50 128/70 130/70 3 6 0 
5 68 70 65 70 79 86 110/76 120/78 130/80 102/70 130/80 128/68 2 0 0 
6 64 70 67 75 80 82 112/78 110/76 124/80 100/60 124/76 128/80 1 0 0 
7 70 75 74 97 100 90 110/78 90/66 126/80 92/50 120/80 120/80 2 6 0 
8 60 86 90 104 99 98 100/62 100/65 114/76 90/40 110/72 112/76 2 24 1.2 
9 58 88 87 100 98 96 100/60 110/58 112/60 96/50 110/60 110/68 2 6 0.6 
10 66 69 64 70 78 80 110/68 100/66 110/70 100/66 110/70 110/70 2 0 0 
11 80 78 74 90 88 84 108/70 110/68 120/70 100/60 120/70 120/70 2 0 0 
12 80 82 78 89 90 90 90/58 110/78 120/80 110/66 112/68 120/70 2 6 0 
13 72 69 64 70 77 78 100/70 108/70 110/70 90/40 110/70 112/70 1 12 1.2 
14 74 78 70 75 80 82 120/69 100/66 124/78 100/50 100/70 100/78 2 12 0 
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15 75 78 78 88 98 95 110/70 100/60 112/80 98/46 110/60 112/64 2 6 0 
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CLONIDINE GROUP 
S.No Name/I.P.No. Age 
/Sex 
Procedure ASA 
status 
Height  Weight Level of 
SAB 
Maximum 
Sensory Level 
Blocked 
Time to 
achieve 
maximum 
sensory level 
Onset of Grade   
4 motor block 
Sensory 
regression 
to L1 
Regression to 
Grade 1 motor 
block 
1 Thanikachalam 
914570 
27/M Right femur 
IMIL nailing  
1 169 65 L3-4 T7 20 5 200 285 
2 Kuppan 
922553 
40/M Left Tibia 
Ilizarov ring 
fix. 
1 156 80 L3-4 T6 40 5 190 225 
3 Ravi 
926492 
34/M Left femur 
DHS fix. 
2 173 69 L3-4 T5 40 3 300 315 
4 Manimaran 
922619 
34/M Right tibia 
IMIL nailing 
1 168 75 L3-4 T7 20 4 280 300 
5 Annamalai 
930614 
40/M Left tbia 
Ilizarov ring 
revision 
1 172 84 L3-4 T5 25 6 310 300 
6 Vishal 
925616 
38/M Right Tibia 
IMIL nailing 
2 165 80 L3-4 T4 20 7 260 270 
7 Pooammal 
924310 
35/F Left  Tibia 
IMIL nailing 
1 157 75 L3-4 T5 25 5 290 300 
8 Priya 
933646 
24/F Right Ilizarov 
ring fix. 
1 162 70 L3-4 T5 30 8 260 290 
9 Jagan 
923414 
21/M Left tibia IMIL 
nailing 
1 168 74 L3-4 T4 25 6 220 240 
10 Divya 
936610 
28/F Left femur 
IMIL nailing 
1 163 58 L3-4 T2 20 10 250 260 
11 Manoharan 
937879 
38/M Left tibia IMIL 
nailing 
2 158 55 L3-4 T5 20 4 210 245 
12 Girija 
937910 
40/F Left Ilizarov 
ring revision 
1 160 62 L3-4 T6 18 5 240 255 
13 Flora 
915674 
36/F Right femur 
DHS fix. 
1 164 66 L3-4 T5 22 6 260 275 
14 Jeeva 
9118903 
32/M Left Tibia 
IMIL nailing 
1 170 72 L3-4 T4 17 4 230 250 
15 Somesh 
934562 
25/M Left tibia ORIF 
and plating 
1 165 70 L3-4 T5 21 8 260 290 
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S.No Heart rate  5 
min 
Heart rate 
10 min 
Heart rate 
15 min. 
Heart rate 
30 min. 
Heart rate 
60 min. 
Heart 
rate 90 
min 
BP at 5 
min 
BP at 10 
min  
BP at 15 
min 
BP at 30 
min 
BP at 60 
min 
BP at 90 
min. 
Ramsey 
Sedation 
Score 
Ephedrine 
(mg) 
Atropine 
(mg) 
1 60 60 62 64 66 66 90/50 94/56 102/50 96/46 100/60 110/62 3 12 1.2 
2 54 52 50 60 58 59 90/62 80/46 96/60 70/40 112/70 112/68 4 30 1.2 
3 62 64 64 68 70 72 90/50 90/43 114/62 80/50 118/60 120/60 4 24 0 
4 68 68 70 87 75 74 90/60 100/58 110/60 100/50 116/72 120/72 3 6 0 
5 78 72 73 90 80 82 94/58 92/62 124/66 100/60 124/66 120/60 3 6 0 
6 66 66 68 70 74 70 98/56 100/60 112/60 90/50 110/70 110/68 4 12 0 
7 67 69 65 73 76 72 86/42 98/50 110/64 92/44 110/60 110/60 4 18 0 
8 68 65 68 69 70 70 90/48 100/66 112/60 90/40 124/80 112/78 4 18 0 
9 72 72 74 78 70 73 90/50 90/48 92/66 90/60 120/70 120/78 3 6 0 
10 68 68 70 70 65 68 100/58 100/60 110/60 100/50 110/60 110/70 3 6 0 
11 59 57 58 60 64 62 100/58 110/66 120/70 90/50 120/70 118/70 4 24 0.6 
12 67 69 66 70 72 70 110/70 100/68 110/70 90/46 110/58 110/68 4 12 0 
13 62 68 69 75 71 70 100/68 120/76 136/80 96/40 124/60 120/60 4 18 0 
14 54 54 52 63 59 60 90/60 100/60 124/78 98/42 112/60 114/70 3 24 1.2 
15 54 55 58 65 62 64 92/68 100/64 120/78 90/40 100/58 110/60 3 18 1.2 
 
